臺灣博碩士論文加值系統

幾個世紀以來，中國人使用傳統中草藥治病，早已成為生活中的一部份。鑑於我國民眾經常使用傳統中草藥，本研究將檢視急診病患中初步診斷為非病毒性肝炎，且曾經使中藥草之頻率。我們將藉由研究設計及統計學方法探討肝炎與使用中草藥的關聯性。據我所知，本實驗是首次在病患抵達急診處時即探討非病毒性肝炎與使用中草藥是否相關之研究。我們希望證實草藥與疾病相關，並造成病患必須到急診就診。本研究為前瞻性病例對照研究之設計，其中收入非病毒性肝炎病患。在密集取樣後，我們收集資料並以邏輯廻歸來分析。本研究收集的70個案及140對照組。經統計分析之後，兩組在單一變數分析後，喝酒，使用過草藥，發病前使用著草藥，及使用西藥對發病在統計上有意義。在多變數分析後，使用草藥在發病前3個月內，及同時使用西藥是跟疾病由相關。雖然個案數目並不多，可是本研究顯示使用草藥及西藥是與非病毒性肝炎有相關。至於草藥與非病毒性肝炎的因果關係，是需要更進一步研究才能得到結論。

The use of Chinese herbal medicine to maintain health among the Chinese ethnic group is deeply rooted in the Chinese way of living for centuries. Since there is a high prevalence in the usage in Taiwan, our study aims to study the relationship of herbal use and visits to the emergency department under the diagnosis of acute non-viral hepatitis. This study is a prospective, density sampling case control study in which patients with non-viral hepatitis was questioned for herbal use. An univariate analysis and conditional logistic regression analysis using the PHPREG procedure in SAS 9.0 (SAS Institute Inc.) was preformed with a discreet logistic model stratified by matching variables. Seventy cases were matched to 140 controls. In the univariate model, long term use of drugs, history of western drugs used, history of herb use, alcohol consumption, recent use of herbs gave an increase in the risk of developing acute non viral hepatitis. After multiplicative conditional logistic regression, we find that the use of herbs within a 3-month period and the concurrent use of western drug pose the greatest threat of acute non-viral hepatitis. We concluded that herbs and drugs used prior to developing acute non viral hepatitis is associated with the development of the disease. Due to the small sample size of this study, there is a need for further study to correctly identifying the cause-effect relationship of herbs and hepatitis, so that further inferences can be made.

Acknowledgements 2
中文摘要 3
英文摘要 4
Background 6
Material and Method 10
1. Recruitment of study subjects 10
2. Serological exam 11
3. Structured questionnaire and standardized interview 11
4. Statistical analysis 12
Results 14
Discussion 18
Conclusion 24
Tables
Table 1 25
Table 2 26
Table 3 27
Reference 29
Appendix
Appendix 1 32
Appendix 2 33

1.Stedman C. Herbal Hepatotoxicity. Semin Liv Dis. 2002; 22: 195-206.
2.Moss TM. Herbal medicine in the emergency department: a primer for toxicities and treatment. J Emerg Nurs 1998; 24:509-13.
3.Chitturi S, Farrel GC. Herbal hepatotoxicity: An expanding but poorly defined problem. J Gasto Hepatol. 2000; 15: 1093-99
4.Schiano TD. Hepatotoxicity and complementary and alternative medicines. Clinic Liver Dis. 2003; 7:453-73.
5.Perharic L, Shaw D, Murray V. Toxic effects of herbal medicines and food supplement. Lancet 1993; 342: 180-81.
6.Normelle D. The new face of traditional Chinese medicine. Science 2003; 299: 188-90.
7.Estes JD, Stolpman D, Olyaei A, et al. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg 2003; 138: 852-58.
8.Hepatic toxicity possibly associated with kava containing products- United States, Germany, and Switzerland, 1999-2002. MMWR. 2002; 51:1065-67.
9.Bajj J, Knox JF, Komorowski R, et al. The irony of herbal hepatitis ma-Huang-induced hepatotoxicity associated with compound heterozygosity for hereditary hemochromatosis. Dig Dis Sci 2003; 48: 1925-58.
10.Saad B, Azaizeh H, Abu-Hijleh G, et al. Safety of traditional Arab herbal medicine. eCAM. 2006; 3:433-39.
11.Kew J, Morris C, Ainie A, Fysh R, et al. Arsenic and mercury intoxication due to Indian ethnic remedies. BMJ 1993; 306:506-7.
12.Cheng TJ, Wong RH, Lin YP, et al. Chinese herbal medicine, sibship, and blood lead in children. Occup Enivron Med 1998; 55: 573-76.
13.Huang WF, Wen KC, Hsiao ML. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol 1997; 37: 344-50.
14.Ernst E. Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review. J Intern Med 2002; 252: 107-13.
15.Chen CJ, Wang LY, Chien YC. News from Taiwan. Hepatol 2004; 39(5):1196.
16.Shivakumar C, Farrell GC. Herbal hepatotoxicity: an expanding but poorly defined problem. J Gastro Hepatol 2000:15; 1093-99.
17.Strader DB, Bacon BR, Lindsay KL, et al. Use of complementary and alternative medicine in patients with liver disease. Am J Gastro 2002; 97; 2391-97.
18.Benichou C. Criteria of drug-induced liver disorders. J Hepatol. 1990;11: 272-6.
19.Navarro VJ, Senior JR. Drug related hepatotoxicity. NEJM.2006; 354 (7): 731-9
20.Stickel F, Patsenker I, Schuppan D. Herbal hepatotoxicity. J Hepatol. 2005;43:910.
21.Favreau JT, Ryu ML, Braunstein G, et al. Severe hepatotoxicity associated with the dietary supplement LipoKinetix. Ann Intern Med. 2002; 136: 590-95.
22.Adachi M, Saito H, Kobayashi H, et al. Hepatic injuries in 12 patients taking the herbal weight loss aids chaso or onshido. Ann Intern Med. 2003; 139: 488-92.
23.Itoh S, Marutani K, Nishijima T, et al. Liver injuries induced by herbal medicine: Syo-saiko-to (siao-chai-hu-tang). Dig Dis Sci. 1995; 490:1845-48.
24.Lynch CR, Folkers ME, Hutson WR. Fulminant hepatic failure assosicated with the use of black cohosha case report. Live Transpl. 2006;12:989-92.
25.Kane JA, Kane SP, Jain S. Hepatitis induced by tranditional Chinese herbs: possible toxic component. Gut. 1995; 36:146-7.
26.Hsu LM, Huang YS, Chang FY, et al. Fat-burner herb, usnic scid, induced acute hepatitis in a family. J Gastroenterol Hepatol. 2005; 20:1138-9.
27.McRae CA, Agawae K, Multimer D, et al. Hepatitis associated with Chinese herbs. Eur J Gastroentrol Hepatol. 14:559-62.
28.Starakis I, Siagris D, Leonidou L, et al. Hepatitis caused by the herbal remedy Teucrium poliium L. Eur J Gastroentrol Hepatol. 2006; 18:681-3.
29.Woolf GM, Petrovic LM, Rojter SE, et al. Acute hepatitis associated with the Chinese herbal products Jin Bu Huan. Ann Intern Med. 1994;121: 729-35.
30.MacGregor FB, Abernethy VE, Dahabra S, et al. Hepatotoxicity of herbal remedies. BMJ. 1989; 299; 1156-57.
31.Larrey D, Pageaux GP. Hepatotoxcity of herbal remedies and mushrooms. Semin Liv Dis. 1995;15:183-8.
32.Farrell GC. Drug-induced hepatic injury. J Gastroenterol Hepatol. 1997;12: S242-50.
33.Larrey D. Hepatotoxicity of herbal remedies. J Hepatol. 1997; 26:47-51.
34.Furbee RB, Barlotta KS, Allen MK, et al. Hepatoxicity associate with herbal products. Clin Lab Med. 2006;26:227-41.
35.Deng JF. Clinical and laboratory investigation in herbal poisoning. Toxicology, 2002; 181: 571-6.
36.Stickel F, Egaerer G, Seitz HK. Hepatoxocity of botanicals. Pub Heal Nurtr.2000;3: 113-24.
37.Fogden E., Neuberger J. Alternative medicines and the liver. Liver. 2003; 23:213-20.
38.Willett KL, Roth RA, Walker L. Workshop overview: hepatotoxcity assessment for botanical dietary supplements. Toxicol Sci. 2004; 79:4-9.
39.Charlton M. Branched-chain amino acid enriched supplements as therapy for lover disease. J Nutr. 2006;136:295S-8S.
40.Brazier NC, Levine MA. Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals. Am J Therap. 2003; 10: 163-9.
41.Abebe W. Herbal medication: potential for adverse interactions with analgesic drugs. J Clinc Phar Therap. 2002; 27:391-401.
42.Miller LG. Herrbal Medicinals. Arch Intern Med 1998; 158:2200-2211.
43.Chitturi S, George J. Hepatoxocity of commonly used drugs: Non-steroid anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid lowering agents, psychotropic drugs. Semin Liv Dis. 2002;22:169-83.
44.Huang HC, Huang YS, Wu JC, et al. Characteristics of autoimmune hepatitis in Taiwan: the 11 years'' experiences of a medical center. Zhonghua Yi Xue Za Zhi. 2002 Dec;65(12):563-9
45.危險物及有害物通識規則accessed May 9, 2007. http://www.iosh.gov.tw/data/f4/law44.htm